$1.9 B

FOLD Mkt cap, 04-Dec-2018
Amicus Therapeutics EBIT (Q3, 2018)-156.2 M
Amicus Therapeutics Cash, 30-Sep-2018201.8 M

Amicus Therapeutics Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

363.0k1.2m5.0m36.9m

Revenue growth, %

(99%)(100%)

Cost of goods sold

833.0k6.2m

Gross profit

4.1m30.7m

Gross profit Margin, %

83%83%

R&D expense

41.9m76.9m104.8m149.3m

General and administrative expense

18.9m47.3m71.2m88.7m

Operating expense total

64.5m130.4m186.0m472.7m

Depreciation and amortization

1.7m1.8m3.2m3.6m

EBIT

(64.2m)(68.7m)(130.4m)(181.9m)(442.0m)

EBIT margin, %

(17681%)(5613%)(3669%)(1197%)

Interest expense

46.0k1.5m1.6m5.4m17.2m

Interest income

174.0k223.0k929.0k1.6m4.1m

Pre tax profit

(63.1m)(132.1m)(203.8m)(449.1m)

Income tax expense

3.5m1.1m1.1m3.7m165.1m

Net Income

(59.6m)(68.9m)(132.1m)(200.0m)

Amicus Therapeutics Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

43.6m24.1m69.5m187.0m49.1m

Accounts Receivable

1.3m9.5m

Inventories

5.5m2.9m2.6m3.4m4.6m

Current Assets

88.3m154.6m216.6m340.1m392.0m

Goodwill

11.6m11.6m197.8m197.8m197.8m

Total Assets

127.6m210.0m908.4m1.0b627.0m

Accounts Payable

10.2m16.3m32.2m185.5m

Short-term debt

Current Liabilities

10.5m20.2m73.6m111.0m70.0m

Long-term debt

Total Debt

Additional Paid-in Capital

423.6m568.7m917.5m1.1b1.4b

Retained Earnings

(447.4m)(579.6m)(779.6m)(1.1b)

Total Equity

45.8m122.2m347.8m360.2m352.9m

Financial Leverage

2.8 x1.7 x2.6 x2.9 x1.8 x

Amicus Therapeutics Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(59.6m)(68.9m)(132.1m)(200.0m)(284.0m)

Depreciation and Amortization

1.7m1.5m1.8m3.2m3.6m

Accounts Receivable

(1.4m)(7.7m)

Inventories

(3.2m)2.3m308.0k(3.7m)(897.0k)

Accounts Payable

6.2m15.5m7.1m

Cash From Operating Activities

(45.8m)(51.7m)(100.1m)(150.5m)(215.5m)

Purchases of PP&E

(695.0k)(238.0k)(4.8m)(6.0m)(4.5m)

Cash From Investing Activities

(145.3m)(4.5m)(171.2m)

Cash From Financing Activities

139.2m290.9m272.7m247.4m

Interest Paid

30.0k1.2m605.0k3.0m7.4m

Amicus Therapeutics Ratios

USDY, 2018

Financial Leverage

2 x
Report incorrect company information

Amicus Therapeutics Employee Rating

3.218 votes
Culture & Values
3.6
Work/Life Balance
3.5
Senior Management
3.3
Salary & Benefits
3.5
Career Opportunities
3.4
Source